Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Receivables - Other (2016)

Historic Receivables - Other for Bio-Techne (TECH) over the last 7 years, with Q1 2016 value amounting to $1.1 million.

  • Bio-Techne's Receivables - Other rose 1305.73% to $1.1 million in Q1 2016 from the same period last year, while for Mar 2016 it was $1.1 million, marking a year-over-year increase of 1305.73%. This contributed to the annual value of $954000.0 for FY2015, which is 8661.43% down from last year.
  • Bio-Techne's Receivables - Other amounted to $1.1 million in Q1 2016, which was up 1305.73% from $1.2 million recorded in Q4 2015.
  • Bio-Techne's 5-year Receivables - Other high stood at $7.1 million for Q2 2014, and its period low was $668000.0 during Q3 2014.
  • Moreover, its 5-year median value for Receivables - Other was $1.8 million (2012), whereas its average is $1.9 million.
  • Its Receivables - Other has fluctuated over the past 5 years, first surged by 25778.11% in 2014, then crashed by 8661.43% in 2015.
  • Bio-Techne's Receivables - Other (Quarter) stood at $2.1 million in 2012, then dropped by 0.42% to $2.1 million in 2013, then crashed by 44.9% to $1.2 million in 2014, then increased by 1.88% to $1.2 million in 2015, then fell by 10.88% to $1.1 million in 2016.
  • Its last three reported values are $1.1 million in Q1 2016, $1.2 million for Q4 2015, and $972000.0 during Q3 2015.